Surgery – Instruments – Cyrogenic application
Reexamination Certificate
2001-01-26
2003-07-15
Dvorak, Linda C. M. (Department: 3739)
Surgery
Instruments
Cyrogenic application
C606S021000
Reexamination Certificate
active
06592577
ABSTRACT:
STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH
Not Applicable.
FIELD OF THE INVENTION
The present invention relates to a coolant system for a catheter or treatment wand used for cryotreatment of tissue. In particular, the coolant system is of the type which connects to a catheter and pumps coolant through the catheter to chill a region of the catheter, such as the distal tip, for treating tissue.
BACKGROUND OF THE INVENTION
A number of cooled catheter systems have been developed for treating tissue in a cardiac setting, either to cool the tissue sufficiently to stun it and allow cold mapping of the heart and/or confirmation of catheter position with respect to localized tissue lesions, or to apply a more severe level of cold to ablate tissue at the site of the catheter ending. In general, the range of treatments which may be effected by a cryocatheter is comparable to the range of applications for radio frequency or thermal ablation catheters, and in particular, these instruments may be configured to achieve either small localized ball shape lesions at the tip of the catheter, or one or more elongated linear lesions extending a length of several centimeters or more along the tip. The latter form of lesion is commonly used to achieve conduction block across a region of the cardiac wall so as to sever an aberrant pathway over a length, preventing conduction across the region, in order change the cardiac signal path topology, for example, to eliminate a faulty pathway responsible for atrial fibrillation or a tachycardia.
In general, when used for endovascular access to treat the cardiac wall, catheters of this type, in common with the corresponding earlier-developed radio frequency or electrothermal ablation catheter, must meet fairly demanding limitations regarding their size, flexibility, and the factors of strength, electrical conductivity and the like which affect their safety and may give rise to failure modes in use. These constraints generally require that the catheter be no larger than several millimeters in diameter so as to pass through the vascular system of the patient to the heart. Thus, any electrodes (in the case of mapping or RF/electrothermal ablation catheters), and any coolant passages (in the case of cryocatheters) must fit within a catheter body of small size.
A number of different fluids have been used for the coolant component of prior art cryotreatment catheters, such as a concentrated saline solution or other liquid of suitably low freezing point and viscosity, and of suitably high thermal conductivity and heat capacity, or a liquified gas such as liquid nitrogen. In all such constructions, the coolant must circulate through the catheter, thus necessitating multiple passages leading to the cooling area of the tip from the catheter handle.
Furthermore, conditions of patient safety must be considered, raising numerous problems or design constraints for each particular system. Thus for example, a high pressure may be required to circulate sufficient coolant through the catheter body to its tip and back, and the overall design of a catheter must be such that fracture of the catheter wall or leakage of the coolant either does not occur, or if it occurs, is harmless. Further, for an endovascular catheter construction, the presence of the coolant and circulation system should not substantially impair the flexibility or maneuverability of the catheter tip and body.
To some extent these considerations have been addressed by using a phase change material as the cryogenic fluid, and arranging the catheter such that the phase change, e.g., from a liquid to a gas, occurs in the treatment portion of the catheter tip. Another possible approach is to employ a pressurized gas, and configure the catheter for cooling by expansion of the gas in the tip structure. However, owing to the small size that such a catheter is required to assume for vascular insertion, or the awkwardness of handling a cryogenic treatment probe generally, the design of a safe and effective coolant circulation system which nonetheless dependably provides sufficient cooling capacity at a remote tip remains a difficult goal.
Among other common problems to be addressed while providing adequate thermal capacity, may be noted the leakage problem mentioned above, the problem of effectively preventing the catheter as a whole from being excessively cold or damaging tissue away from the intended site, and the problem of conduit or valve blockage owing for example to ice particles and the like.
Accordingly, it would be desirable to provide a coolant system which conveniently attaches to a cryocatheter.
It would also be desirable to provide a coolant system which injects and retrieves the coolant from the catheter to allow continuous operation without leakage into the environment or other loss of coolant.
It would further be desirable to provide a treatment system which precisely controls ablation and treatment regimens by conditioning the coolant supply at various point along the fluid path.
SUMMARY OF THE INVENTION
These and other desirable features are obtained in a coolant system that includes a medical device and a console connectable to the medical device at a connection point. The console controls the temperature of the medical device. The console includes a first cooling system directing coolant to the medical device at a first temperature along a coolant supply line and a second cooling system chilling the coolant within the coolant supply line to a temperature below the first temperature before the coolant reaches the connection point.
REFERENCES:
patent: 3823575 (1974-07-01), Parel
patent: 3859986 (1975-01-01), Okada et al.
patent: 5275595 (1994-01-01), Dobak, III
patent: 5651780 (1997-07-01), Jackson et al.
patent: 5658278 (1997-08-01), Imran et al.
patent: 5674218 (1997-10-01), Rubinsky et al.
patent: 5743903 (1998-04-01), Stern et al.
patent: 5758505 (1998-06-01), Dobak, III et al.
patent: 5807391 (1998-09-01), Wijkamp
patent: 5957963 (1999-09-01), Dobak, III
patent: 6007571 (1999-12-01), Neilson et al.
patent: 6016661 (2000-01-01), Sagar
patent: 6019783 (2000-02-01), Philips et al.
patent: 6027499 (2000-02-01), Johnston et al.
patent: 6027500 (2000-02-01), Buckles et al.
patent: 6032675 (2000-03-01), Rubinsky
patent: 6033383 (2000-03-01), Ginsburg
patent: 6039730 (2000-03-01), Rabin et al.
patent: 6051019 (2000-04-01), Dobak, III
patent: 6096068 (2000-08-01), Dobak, III et al.
patent: 6106518 (2000-08-01), Wittenberger et al.
patent: 6146411 (2000-11-01), Noda et al.
patent: 6149677 (2000-11-01), Dobak, III et al.
patent: 6161543 (2000-12-01), Cox et al.
patent: 6190378 (2001-02-01), Jarvinen
patent: 6193644 (2001-02-01), Dobak, III et al.
patent: 6235048 (2001-05-01), Dobak, III
patent: 6241722 (2001-06-01), Dobak et al.
patent: 6306129 (2001-10-01), Little et al.
patent: 0 651 308 (1995-03-01), None
patent: 2 026 324 (1980-02-01), None
patent: 96/30816 (1996-10-01), None
patent: 98/37822 (1998-09-01), None
patent: 99/56639 (1999-11-01), None
patent: 99/56640 (1999-11-01), None
patent: 99/56641 (1999-11-01), None
patent: WO 99/57494 (1999-11-01), None
patent: 00/35362 (2000-06-01), None
patent: WO 01/01049 (2001-01-01), None
Abboud Marwan
Lalonde Jean-Pierre
Mahrouche Rachid
Wittenberger Dan
Christopher & Weisberg P.A.
CryoCath Technologies Inc.
Dvorak Linda C. M.
Ruddy David M.
LandOfFree
Cooling system does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cooling system, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cooling system will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3099590